Cargando…
SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons. Mutations in the SPTLC1 subunit of serine palmitoyltransferase (SPT), which catalyzes the first step in the de novo synthesis of sphingolipids (SLs), cause childhood-onset ALS. SPTLC1-ALS varia...
Autores principales: | Lone, Museer A., Aaltonen, Mari J., Zidell, Aliza, Pedro, Helio F., Morales Saute, Jonas A., Mathew, Shalett, Mohassel, Payam, Bönnemann, Carsten G., Shoubridge, Eric A., Hornemann, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479574/ https://www.ncbi.nlm.nih.gov/pubmed/35900868 http://dx.doi.org/10.1172/JCI161908 |
Ejemplares similares
-
Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts
por: Karsai, Gergely, et al.
Publicado: (2021) -
New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1
por: Kölbel, Heike, et al.
Publicado: (2022) -
ORMDL3 and Asthma: Linking Sphingolipid Regulation to Altered T Cell Function
por: Luthers, Christopher R., et al.
Publicado: (2020) -
CRISPR/Cas9 deletion of ORMDLs reveals complexity in sphingolipid metabolism
por: Green, Christopher D., et al.
Publicado: (2021) -
Ceramide sensing by human SPT-ORMDL complex for establishing sphingolipid homeostasis
por: Xie, Tian, et al.
Publicado: (2023)